Scar News and Research

RSS

Genetic code of sudden death cardiac killer cracked

Researchers in Newfoundland have cracked the genetic code of a sudden death cardiac killer.

26 Oct 2010

Matrix-Bio's VeraMarker-BCR blood test predicts breast cancer recurrence 13 months before clinical diagnosis

Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain, and ovarian cancer before succumbing to the disease in their early 50s.

21 Oct 2010

Jefferson researchers progress in understanding mechanism behind systemic fibrotic disorder

Scientists from the Jefferson Institute of Molecular Medicine of Thomas Jefferson University are now several steps closer to understanding the mechanism behind a novel systemic fibrotic disorder that affects some patients with renal insufficiency who receive imaging contrast agents for MRI. Two of their studies on the disorder appear together in the November issue of the Annals of Rheumatic Diseases.

20 Oct 2010

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.

18 Oct 2010

2010 AAO-MEACO meeting focuses on genetic medicine

Genetic medicine is the focus of two presentations at today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session October 16 through 19 at McCormick Place, Chicago. It is the largest, most comprehensive ophthalmic education conference in the world.

18 Oct 2010

Auxilium commences dosing in global XIAFLEX phase III program for Peyronie's disease

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first subject has been dosed in the global phase III program of XIAFLEX® for the treatment of Peyronie's disease. Peyronie's disease is the development of scar tissue on the penis that can cause the penis to curve during erection, often interfering with or preventing intercourse and resulting in psychological distress or bother for the patient.

11 Oct 2010

Mouse study may help develop new therapies for spinal cord injury

Researchers at Karolinska Institutet have shown how stem cells, together with other cells, repair damaged tissue in the mouse spinal cord. The results are of potential significance to the development of therapies for spinal cord injury.

8 Oct 2010

Mt. Sinai surgeons pioneer scar-free gallbladder removal

A team of surgeons from Mt. Sinai Hospital in New York who have pioneered scar-free gallbladder removal are offering the procedure to all suitable patients and extending this new type of surgical procedure to other operations in the abdomen. They reported on their updated findings today at the 2010 Annual Clinical Congress of the American College of Surgeons.

6 Oct 2010

Scientists use directed light to cause arrhythmia in genetically modified mice

Scientists at the University of Bonn have altered cardiac muscle cells to make them controllable with light. They were thus able to use directed light to cause conditions such as arrhythmia in genetically modified mice. The method opens up completely new possibilities for researching the development of such arrhythmias. The study will be published in the upcoming edition of "Nature Methods".

5 Oct 2010

Integra LifeSciences launches EGR system in the U.S.

Integra LifeSciences Holdings Corporation announced today the launch of the Integra™ Endoscopic Gastroc Release (EGR) System in the United States. Integra's EGR System is a disposable device with a unique articulating blade that allows selective cutting of soft tissues. It is intended for use in the surgical treatment for posterior heel cord, or equinus, contracture.

4 Oct 2010

Researchers create new cell lines from mesenchymal stem cells

Biomedical researchers at the University at Buffalo have engineered adult stem cells that scientists can grow continuously in culture, a discovery that could speed development of cost-effective treatments for diseases including heart disease, diabetes, immune disorders and neurodegenerative diseases.

4 Oct 2010

NIH awards three grants to explore novel treatment strategies for muscular dystrophy

Three grants totaling more than $4.5 million, from agencies of the National Institutes of Health, will be used to explore novel treatment strategies for muscular dystrophy.

30 Sep 2010

USPTO issues Notice of Allowance for INSORB Skin Closure technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for another key patent application, "Mechanical Method and Apparatus for Tissue Fastening." The allowed claims include subject matter covering the method of the INSORB Skin Closure technology and specific stapler features.

28 Sep 2010

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.

28 Sep 2010

TONES procedure is safe and effective for treating brain diseases, traumatic injuries

Surgeons at the University of California, San Diego, School of Medicine and University of Washington Medical Center have determined that transorbital neuroendoscopic surgery is a safe and effective option for treating a variety of advanced brain diseases and traumatic injuries. This groundbreaking minimally invasive surgery is performed through the eye socket, thus eliminating the removal of the top of the skull to access the brain.

27 Sep 2010

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

Van Andel Research Institute (VARI) scientists participated in a study with researchers from the University of Utah that could help find ways to improve shunt systems used to treat the neurological disorder hydrocephalus, or "water on the brain," the leading cause of brain surgery for children in the United States. Researchers studied the shunt systems under a variety of conditions by creating a bioreactor that mimics the environment inside patients.

24 Sep 2010

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

St. Jude Medical, Inc., a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device Registry. The results reaffirm the excellent sealing performance of the Angio-Seal Evolution vascular closure device in patients undergoing routine diagnostic and interventional cardiac catheterization procedures.

22 Sep 2010

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

Development of a potential treatment for the most common form of muscular dystrophy is moving into a new phase at Brown University. Brown has granted an exclusive license for the intellectual property to Tivorsan Pharmaceuticals, a startup firm that will strive to see it through human trials.

22 Sep 2010

New study shows impact of violence on Palestinian, Israeli children

As another round of talks continues between Israelis and Palestinians, a new University of Michigan study documents the impact the violence has been inflicting on the region's children.

17 Sep 2010

New imaging technique visualizes myocardial scar and heart's blood vessels simultaneously

Cardiologists and surgeons may soon have a new tool to improve outcomes for patients requiring pacemakers, bypass surgery or angioplasties. Research led by Dr. James White and his colleagues at The University of Western Ontario has led to a new imaging technique, which provides a single, 3D high-resolution image of the heart revealing both its vasculature and the presence of scar tissue within the muscle.

17 Sep 2010

Scar News and Research

Genetic code of sudden death cardiac killer cracked

Matrix-Bio's VeraMarker-BCR blood test predicts breast cancer recurrence 13 months before clinical diagnosis

Jefferson researchers progress in understanding mechanism behind systemic fibrotic disorder

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

2010 AAO-MEACO meeting focuses on genetic medicine

Auxilium commences dosing in global XIAFLEX phase III program for Peyronie's disease

Mouse study may help develop new therapies for spinal cord injury

Mt. Sinai surgeons pioneer scar-free gallbladder removal

Scientists use directed light to cause arrhythmia in genetically modified mice

Integra LifeSciences launches EGR system in the U.S.

Researchers create new cell lines from mesenchymal stem cells

NIH awards three grants to explore novel treatment strategies for muscular dystrophy

USPTO issues Notice of Allowance for INSORB Skin Closure technology

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

TONES procedure is safe and effective for treating brain diseases, traumatic injuries

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

New study shows impact of violence on Palestinian, Israeli children

New imaging technique visualizes myocardial scar and heart's blood vessels simultaneously

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News